ĐÁNH GIÁ TÌNH HÌNH GHÉP TẾ BÀO GỐC TẠO MÁU TỰ THÂN TẠI BỆNH VIỆN TRUNG ƯƠNG QUÂN ĐỘI 108 GIAI ĐOẠN 2024-2026
Objective: To evaluate the preliminary outcomes of autologous hematopoietic stem cell transplantation (ASCT) at 108 Military Central Hospital during the period 2024–2026.Subjects and methods: We conducted a retrospective study with post-transplant follow-up in patients with multiple myeloma and lymphoma who underwent ASCT between March 2024 and March 2026. A total of 37 patients received high-dose chemotherapy followed by ASCT, including 24 patients with multiple myeloma and 13 patients with lymphoma. All patients were followed until the end of the study period. The evaluated parameters included disease characteristics, infused CD34+ cell dose, time to neutrophil and platelet engraftment, transplant-related complications, and patient status as of March 2026.Results: Thirty-seven patients underwent ASCT, including 24 patients with multiple myeloma (64.9%) and 13 patients with lymphoma (35.1%). In the multiple myeloma group, the mean age at transplantation was 51.3 ± 6.3 years, with a male-to-female ratio of 2.4:1. Most patients achieved a very good partial response (VGPR) or partial response (PR) before transplantation. The mean infused stem cell dose was 5.4 × 10⁶ CD34+ cells/kg body weight. Mean times to neutrophil and platelet engraftment were 9.9 and 9.7 days, respectively. In the lymphoma group, 92.3% of patients achieved complete remission (CR) before transplantation. The mean infused stem cell dose was 5.9 × 10⁶ CD34+ cells/kg body weight. Mean times to neutrophil and platelet engraftment were 9.2 and 8.8 days, respectively.Successful engraftment was achieved in all patients. The most common complications were nausea and vomiting (86.5%), diarrhea (67.6%), and fever (54.1%). No transplant-related mortality was observed during hospitalization.Conclusion: Autologous hematopoietic stem cell transplantation at 108 Military Central Hospital was safely and effectively implemented, achieving a 100% engraftment rate, rapid hematologic recovery, and an acceptable toxicity profile.
Authors
- Văn Hiếu Phạm
- Phạm Thị Tuyết Nhung (ORCID: https://orcid.org/0009-0002-7995-0158)
- Thị Thanh Long Phan
- Thanh Hương Nguyễn
- Thị Thu Huyền Lê
- Thị Hương Giang Nguyễn
Publication Details
- Journal
- Journal of Clinical Medicine Bach Mai Hospital
- Published
- 2026-11-21
- DOI
- https://doi.org/10.52322/jocmbmh.156.0309
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00